New Compounding Rule Effective June 22, 2014

Posted in Latest News on July 3, 2014.

Effective June 22, 2014, Board of Pharmacy (Board), Rule 64B16-27.700(3)(g), Florida Administrative Code, requires all pharmacies that engage in office use compounding of sterile products intended for human use be in full compliance with 21 United States Code § 353b, which includes being registered as an outsourcing facility.

The Board has amended this rule so it will not be in conflict with Title I of the Drug Quality and Security Act of 2013 (DQSA) as signed by the President on November 27, 2013. You may view a copy of the adopted rule on the Board’s website at: http://floridaspharmacy.gov/resources/.   For more information on the DQSA, including how to apply as an outsourcing facility, you may access the U.S. Food and Drug Administration website at: http://www.fda.gov/.

Thank you for helping the Board of Pharmacy to protect, promote and improve the health of all people in Florida. If you have any questions you may contact our office by email at info@floridaspharmacy.gov.



More Latest News

Massachusetts Special Commission on Pharmacy Compounding Report
June 12, 2013

In response to the tragic events of the multi-state meningitis outbreak Massachusetts Governor Patrick convened the Special Commission to investigate the oversight of compounding pharmacies. The report, which includes recommendations, was released in January 2013. The Florida Board of Pharmacy … Continue reading


DEA Guidelines to Prescription Fraud
June 12, 2013

Pharmacist’s Guide to Prescription Fraud The purpose of this guide is to ensure that controlled substances continue to be available for legitimate medical and scientific purposes while preventing diversion into the illicit market. It is not the intent of this … Continue reading